Par(-4)oxysm in Breast Cancer

Tripti Shrestha-Bhattarai; Nikhil Hebbar; Vivek M. Rangnekar

doi:10.1016/j.ccr.2013.06.010

Par(-4)oxysm in Breast Cancer

Tripti Shrestha-Bhattarai
, Nikhil Hebbar
, Vivek M. Rangnekar

Research output: Contribution to journal › Short survey › peer-review

10 Scopus citations

Abstract

Women suffering from breast cancer often succumb to incurable recurrent disease resulting from therapy-resistant cancer cells. In this issue of Cancer Cell, Alvarez and colleagues identify downregulation of the tumor suppressor Par-4 as the key determinant in apoptosis evasion, which leads to tumor recurrence in breast cancer.

Original language	English
Pages (from-to)	3-5
Number of pages	3
Journal	Cancer Cell
Volume	24
Issue number	1
DOIs	https://doi.org/10.1016/j.ccr.2013.06.010
State	Published - Jul 8 2013

Bibliographical note

Funding Information:
This work was supported by a KLCR grant and NIH/NCI grant CA060872 (to V.M.R.).

Funding

This work was supported by a KLCR grant and NIH/NCI grant CA060872 (to V.M.R.).

Funders	Funder number
KLCR
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer Institute	R01CA060872

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ccr.2013.06.010

Cite this

@article{acff115f03f148d5ac5522427ca4f0d5,

title = "Par(-4)oxysm in Breast Cancer",

abstract = "Women suffering from breast cancer often succumb to incurable recurrent disease resulting from therapy-resistant cancer cells. In this issue of Cancer Cell, Alvarez and colleagues identify downregulation of the tumor suppressor Par-4 as the key determinant in apoptosis evasion, which leads to tumor recurrence in breast cancer.",

author = "Tripti Shrestha-Bhattarai and Nikhil Hebbar and Rangnekar, \{Vivek M.\}",

note = "Funding Information: This work was supported by a KLCR grant and NIH/NCI grant CA060872 (to V.M.R.).",

year = "2013",

month = jul,

day = "8",

doi = "10.1016/j.ccr.2013.06.010",

language = "English",

volume = "24",

pages = "3--5",

number = "1",

}

TY - JOUR

T1 - Par(-4)oxysm in Breast Cancer

AU - Shrestha-Bhattarai, Tripti

AU - Hebbar, Nikhil

AU - Rangnekar, Vivek M.

N1 - Funding Information: This work was supported by a KLCR grant and NIH/NCI grant CA060872 (to V.M.R.).

PY - 2013/7/8

Y1 - 2013/7/8

N2 - Women suffering from breast cancer often succumb to incurable recurrent disease resulting from therapy-resistant cancer cells. In this issue of Cancer Cell, Alvarez and colleagues identify downregulation of the tumor suppressor Par-4 as the key determinant in apoptosis evasion, which leads to tumor recurrence in breast cancer.

AB - Women suffering from breast cancer often succumb to incurable recurrent disease resulting from therapy-resistant cancer cells. In this issue of Cancer Cell, Alvarez and colleagues identify downregulation of the tumor suppressor Par-4 as the key determinant in apoptosis evasion, which leads to tumor recurrence in breast cancer.

UR - https://www.scopus.com/pages/publications/84880009102

UR - https://www.scopus.com/pages/publications/84880009102#tab=citedBy

U2 - 10.1016/j.ccr.2013.06.010

DO - 10.1016/j.ccr.2013.06.010

M3 - Short survey

C2 - 23845436

AN - SCOPUS:84880009102

SN - 1535-6108

VL - 24

SP - 3

EP - 5

JO - Cancer Cell

JF - Cancer Cell

IS - 1

ER -

Par(-4)oxysm in Breast Cancer

Abstract

Bibliographical note

Funding

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this